Costantino, M.; Giudice, V.; Moccia, G.; Longanella, W.; Caruccio, S.; Tremiterra, G.; Sinopoli, P.; Benvenuto, D.; Serio, B.; Malatesta, F.;
et al. Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study. Vaccines 2024, 12, 990.
https://doi.org/10.3390/vaccines12090990
AMA Style
Costantino M, Giudice V, Moccia G, Longanella W, Caruccio S, Tremiterra G, Sinopoli P, Benvenuto D, Serio B, Malatesta F,
et al. Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study. Vaccines. 2024; 12(9):990.
https://doi.org/10.3390/vaccines12090990
Chicago/Turabian Style
Costantino, Maria, Valentina Giudice, Giuseppina Moccia, Walter Longanella, Simona Caruccio, Giuliana Tremiterra, Pio Sinopoli, David Benvenuto, Bianca Serio, Francesca Malatesta,
and et al. 2024. "Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study" Vaccines 12, no. 9: 990.
https://doi.org/10.3390/vaccines12090990
APA Style
Costantino, M., Giudice, V., Moccia, G., Longanella, W., Caruccio, S., Tremiterra, G., Sinopoli, P., Benvenuto, D., Serio, B., Malatesta, F., Pecoraro, N., Vozzella, E. A., Rossiello, R., Genovese, G., & De Caro, F.
(2024). Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study. Vaccines, 12(9), 990.
https://doi.org/10.3390/vaccines12090990
